Therapeutic Classification: antidotes, antihypertensives
Pharmacologic Classification: alpha adrenergic blockers
REMS
IV, Infiltration
Local
Absorption: Well absorbed following IM administration; IV administration results in complete bioavailability; completely available after local injection.
Distribution: Unknown.
Half-Life: IV: 19 min; Local injection: 23 hr.
(alpha-adrenergic blockade)
ROUTE | ONSET | PEAK | DURATION |
---|---|---|---|
IM | unknown | 20 min | 3045 min |
IV | immediate | 2 min | 1530 min |
Local | rapid | 1020 min | unknown |
Contraindicated in:
Use Cautiously in:
With IV use
CV: angina, arrhythmias, hypotension, MI, tachycardia
Derm: flushing
EENT: nasal stuffiness
GI: abdominal pain, diarrhea, nausea, vomiting, aggravation of peptic ulcer
Local: injection site pain (local)
Neuro: CEREBROVASCULAR SPASM, dizziness, weakness
Drug-drug:
Hypertension Associated with PheochromocytomaBefore/During Surgery
Prevention of Dermal Necrosis during Infusion of Norepinephrine, Phenylephrine, or Dopamine
Treatment of Dermal Necrosis Following Extravasation of Norepinephrine, Phenylephrine, or Dopamine
Infiltrate
(Adults ): 510 mg.Infiltrate
(Children ): 0.10.2 mg/kg (up to 10 mg).Reversal of Intraoral Submucosal Anesthesia Following Dental Procedures (Oraverse)
Infiltrate or Block Injection
(Adults and Children ≥3 yr and >30 kg): Dose administered is based on number of cartridges of local anesthetic with vasoconstrictor administered: ½cartridge local anesthetic: 0.2 mg phentolamine (½ cartridge); 1 cartridge local anesthetic: 0.4 mg phentolamine (1 cartridge); 2 cartridges local anesthetic: 0.8 mg phentolamine (2 cartridges).Infiltrate or Block Injection
(Children ≥3 yr and 1530 kg): Do not exceed dose of 0.2 mg (½ cartridge).IV Administration: